Tech Company M&A Transactions
Impedance Cardiology Systems Acquisition
Impedance Cardiology Systems, based in Menlo Park, was acquired by Abiomed. The parties disclosed the acquisition price to be $29 million.
Transaction Overview
Company Name
Acquired By
Announced On
4/27/2005
Transaction Type
M&A
Amount
$29,000,000
M&A Terms
Under the terms of the agreement ABIOMED will acquire Impella for approximately 4.04 million shares of ABIOMED common stock and approximately $1.8 million in cash. In addition, ABIOMED may make additional contingent payments to Impella shareholders based on stock price performance, unit sales and FDA approval milestones. The contingent payments range on a scale from zero dollars to approximately $29 million. The transaction is subject to customary closing conditions
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
3000 Sand Hill Rd Bldg 4 210
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Email Address
Not Recorded
Overview
The company is performing biotechnology research and development.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Grady Floyd
Browse more venture capital transactions:
Prev: 4/27/2005: Bridgestream venture capital transaction
Next: 4/28/2005: Ice Energy venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs